STAT3 and cancer: Therefore, to evaluate micro-heterogeneity in the expression and cellular distribution of STAT3 in precancer and cancer tissues in situ, immunohistochemical protocol was optimized for analysis of STAT3, pSTAT3(Y705) and pSTAT3(S727) in freshly-collected, paraffinized tissue sections.